Below are the most recent publications written about "Macular Degeneration" by people in Profiles.
-
Park J, Han K, Kim B, Lee K, Jang HR, Yoon JM, Lim DH, Shin DW. Risk of age-related macular degeneration according to the chronic kidney disease and proteinuria in Korea: a 10-year nationwide cohort study. Sci Rep. 2025 Jul 22; 15(1):26595.
-
Swan J, Toomey CB, Bergstrand M, Cuello HA, Robie J, Yu H, Yuan Y, Kooner AS, Chen X, Shaughnessy J, Ram S, Varki A, Gagneux P. The Sialome of the Retina, Alteration in Age-Related Macular Degeneration Pathology, and Potential Impacts on Complement Factor H. Invest Ophthalmol Vis Sci. 2025 Jun 02; 66(6):81.
-
Cheng SY, Giguere D, Silverstein I, Conza A, Seddon JM, Kim S, Iwata T, Mueller C, Punzo C. Role of alpha-1 antitrypsin in Bruch's membrane integrity. Sci Rep. 2025 Apr 10; 15(1):12223.
-
Son KY, Choi YJ, Kim B, Han K, Hwang S, Jung W, Shin DW, Lim DH. Association between Age-Related Macular Degeneration with Visual Disability and Risk of Dementia: A Nationwide Cohort Study. J Am Med Dir Assoc. 2025 Feb; 26(2):105392.
-
Seddon JM, De D, Rosner B. The role of nutritional factors in transitioning between early, mid, and late stages of age-related macular degeneration: prospective longitudinal analysis. Am J Clin Nutr. 2024 Dec; 120(6):1387-1398.
-
Park J, Jung W, Han K, Kim B, Lee SY, Yoon JM, Lim DH, Shin DW. Association between age-related macular degeneration and risk of incident cancer. Br J Ophthalmol. 2024 Aug 22; 108(9):1249-1256.
-
Brown EE, Guy AA, Holroyd NA, Sweeney PW, Gourmet L, Coleman H, Walsh C, Markaki AE, Shipley R, Rajendram R, Walker-Samuel S. Physics-informed deep generative learning for quantitative assessment of the retina. Nat Commun. 2024 Aug 10; 15(1):6859.
-
Munzar R, Roh S, Ramsey DJ. Factors associated with loss to follow-up in patients with advanced age-related macular degeneration: A telehealth recall initiative. Ophthalmic Physiol Opt. 2024 May; 44(3):626-633.
-
Archambault SD, Nichols MM, McCullum JC, Zhang Y, Steinberger EE, Ramsey DJ. Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration. Indian J Ophthalmol. 2024 Jan 01; 72(Suppl 1):S101-S105.
-
Hollitt GL, Qassim A, Thomson D, Schmidt JM, Nguyen TT, Landers J, MacGregor S, Siggs OM, Souzeau E, Craig JE. Genetic Risk Assessment of Degenerative Eye Disease (GRADE): study protocol of a prospective assessment of polygenic risk scores to predict diagnosis of glaucoma and age-related macular degeneration. BMC Ophthalmol. 2023 Oct 24; 23(1):431.